Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPACT: Subcutaneous C1-INH for HAE Prophylaxis
NCT01912456Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jan 2014
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by CSL Limited. Started Jan 2014; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01912456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912456.